Back to User profile » Dr Shunliang Xu

Paper published by Dr Shunliang Xu:


Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis

Xie J, Zhang T, Li P, Wang D, Liu T, Xu S

Drug Design, Development and Therapy 2022, 16:3071-3085

Published Date: 11 September 2022